Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View

Dr. Matthew Kurian

Breast Oncology · St Elizabeth Healthcare

View

Dr. Sarah Premji

Breast Oncology

View

Dr. Roberto Leon-Ferre

Breast Oncology · Mayo Clinic College of Medicine

View

Dr. Nerea Lopetegui-Lia

Breast Oncology · OSUMC

View

Dr. Allison Kurian

Breast Oncology · SU

View

Dr. Minhtri Nguyen

Breast Oncology · Advisor

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    MA

    Dr. Mouni Audeh

    Medical Oncology · Breast Oncology
    Cedars-Sinai Medical Center
    mouni

    Research

    Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial

    2024

    Via Journal of Clinical Oncology

    Research

    A breast cancer gene signature for indolent disease

    2017

    Via Breast Cancer Research and Treatment

    Research

    Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety

    2016

    Via Annals of Oncology

    Research

    Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology

    2015

    Via Current Treatment Options in Cardiovascular Medicine

    Research

    Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

    2015

    Via Gynecologic Oncology

    Research

    Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition

    2014

    Via Pharmacogenomics and Personalized Medicine

    Research

    Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation

    2014

    Via Journal of Clinical Oncology

    Research

    T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood

    2013

    Via Science Translational Medicine

    Research

    Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study

    2013

    Via Investigational New Drugs

    Research

    Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer

    2011

    Via Journal of Clinical Oncology

    Research

    Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

    2010

    Via Lancet

    Research

    Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

    2010

    Via Lancet

    Research

    Letting the genome out of the bottle

    2008

    Via The New England Journal of Medicine

    Research

    A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease

    2006

    Via Journal of Autoimmunity

    Research

    Loss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transport

    2004

    Via Genes & Development